Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How can i apply for vascepa's patient assistance program?How do tums affect lipitor's ability to lower lipid levels?How does Olipudase Alfa treat ASMD?Can Valcyte treat CMV retinitis?Can iron supplements reduce lipitor's efficacy in any way?
See the DrugPatentWatch profile for caplyta
Caplyta (lumateperone) can cause drowsiness in some patients. Sleepiness and sedation are recognized adverse effects for lumateperone, so it can affect how alert a person feels, especially when starting treatment or after dose changes. [1]
Drowsiness is most likely around the start of therapy and during any dose adjustments, when the body is still adjusting to the medication. [1]
If drowsiness occurs, clinicians commonly advise caution with activities that require full alertness (such as driving) until you know how Caplyta affects you. If sleepiness is significant or persistent, it’s important to talk with the prescriber about adjusting the plan. [1]
Yes. Patients may describe multiple “low-energy” symptoms, but the specific issue of sleepiness/sedation is distinct from dizziness and general fatigue. Caplyta labeling includes sleepiness as a possible effect to watch for. [1]
[1] https://www.drugs.com/dosage/caplyta.html
Other Questions About Caplyta :